E

Elanco

Global animal health pharmaceutical company

Executive Director of Business Solutions - Elanco Business Solutions

Full-Time
No salary listed
Expert
MBA
Indianapolis, IN, USA
HybridHybrid work environment at the Indianapolis headquarters; travel to international sites up to 40% annually.
Business & Strategy

About the job

Requirements
  • An MBA or other relevant postgraduate or professional qualification is required.
  • A minimum of 10 years of experience in a leadership role within a multinational shared services or equivalent environment is required.
  • At least 8 years of success managing large, cross-functional senior leadership teams of more than 500 employees across multiple international locations is required.
  • Strong financial and business acumen, including experience in resource allocation and budget management, is required.
  • The ability to develop and execute long-term functional strategic plans is required.
  • Problem-solving and conflict-resolution skills are required.
Responsibilities
  • Develop and execute the global vision, strategy, and operational framework for Elanco's Business Solutions centers, including identifying, influencing, and delivering additional roles moving to the centers.
  • Guide and cultivate a culture of high engagement and performance across a globally distributed organization of up to 1,400 employees.
  • Serve as the single point of accountability for service delivery, continuous improvement, and relationship management with key global business partners.
  • Oversee the transition of new services into the Business Solutions organization, including organizational design, hiring, and training to improve cost efficiency and deliver financial targets and commitments.
  • Ensure robust compliance across all Business Solutions processes and deliver financial targets and business-plan commitments.
  • Maintain direct accountability for Business Solutions administration, Record-to-Report, Purchase-to-Pay, and Order-to-Cash teams and activities totaling approximately 475 employees.
Desired Qualifications
  • Demonstrated expertise in complex, large-scale business transformation projects, including service transitions and technology implementations such as artificial intelligence and automation.
  • A track record of developing high-performing leaders and fostering a culture of continuous improvement and innovation.
  • Experience operating across diverse cultural environments with high self-awareness and a collaborative, inclusive leadership style.
  • Exceptional problem-solving and conflict-resolution skills, including the ability to navigate ambiguity and make results-oriented choices.

About the company

Elanco is a global animal health company that develops medicines, vaccines, and preventive care products for livestock and pets. Its products include prescription medicines, vaccines, and parasite-control solutions used by veterinarians, farmers, and pet owners to protect animal health and welfare and improve productivity. After separating from Eli Lilly in 2019, Elanco expanded its scale by acquiring Bayer Animal Health in 2020, which broadened its reach in the companion-animal market and added direct-to-consumer capabilities. Its goal is to advance animal health and welfare worldwide by providing effective, accessible products and services while growing sustainably as a standalone company.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Indianapolis, Indiana

Founded

1954

Get referred to Elanco

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 5, 2026 Q2 revenue reached $1.368 billion, with 8% organic constant-currency growth.
  • August 26, 2026 Elwood expansion quadrupled mAb capacity, supporting Befrena and Trutect.
  • Elanco raised 2026 innovation revenue to $1.25 billion and targets unconstrained Befrena supply by early 2027.

What critics are saying

  • December 2025 restructuring hit 600 roles and $175 million charges, with closures continuing through 2026.
  • Seventh Circuit affirmed Elanco's securities case on August 14, 2026, keeping disclosure risk alive.
  • Befrena demand is twice expectations; any manufacturing or safety setback would cripple Elanco's biologics thesis.

What makes Elanco unique

  • Elanco owns one of two animal-health monoclonal antibody platforms, centered in Elwood, Kansas.
  • Befrena and Trutect give Elanco proprietary biologics manufacturing control, not outsourced dependence.
  • Elanco spans farm and pet health, unlike narrower companion-animal rivals like Zoetis.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Flexible Work Hours
  • Hybrid Work Options
  • 401(k) Company Match
  • Parental Leave
  • Annual Bonus
  • Relocation Assistance

Growth & Insights and Company News

6 month growth

6%

1 year growth

5%

2 year growth

5%
C-W Valley Co-op
Oct 23rd, 2026
Elanco Animal Health Appoints Jamie Preston As Chief People Officer

Elanco Animal Health Appoints Jamie Preston As Chief People Officer | Published on: Oct 23, 2026

Feed and Additive
Oct 22nd, 2026
Elanco appoints Jamie Preston as Chief People Officer.

Elanco appoints Jamie Preston as Chief People Officer. 22 October 2026 Elanco Animal Health has appointed Jamie Preston as Executive Vice President and Chief People Officer, effective 3 November 2026. Preston brings 23 years of experience from Eli Lilly and will succeed Dave Kinard, who plans to retire at year-end. Elanco Animal Health has named Jamie Preston as its new Executive Vice President and Chief People Officer, following an extensive search. Preston will join the company on 3 November, succeeding Dave Kinard, who intends to retire at the end of 2026. Kinard will work closely with Preston during the transition to ensure continuity in the company's global human resources operations. Preston joins Elanco from Eli Lilly and Company, bringing 23 years of enterprise experience, including nearly two decades of human resources leadership. Most recently, she served as Vice President of HR, Global Compensation and Workforce Innovation, where she led the compensation and recognition team for Lilly's global workforce of more than 50,000 employees and spearheaded enterprise-wide AI and workforce modernization strategies. "Jamie is a visionary, dynamic leader with the speed and agility that defines Elanco. She has deep global experience across every facet of human resources, from organizational design and talent development to workforce innovation and digital transformation," said Jeff Simmons, President and CEO of Elanco. GLOBAL HR LEADERSHIP EXPERIENCE During her tenure at Lilly, which began in the sales organization, Preston held executive HR leadership roles across global markets. She served as Associate Vice President of HR across five Asia-Pacific markets-Australia, New Zealand, Taiwan, Korea and Hong Kong-where she supported the region's growth into a billion-dollar business hub. She also served as HR Director for Lilly Japan, supporting the research and development organization, led global people strategy for the Oncology Business Unit and supported key corporate and manufacturing functions. "Elanco's purpose - food and companionship enriching lives - deeply resonates with me," said Jamie Preston. "I am excited to partner with our global teams to champion our people, advance workforce innovation and cultivate a culture where our talent thrives as we deliver for veterinarians, pet owners, farmers and the animals in their care." Beyond her corporate leadership, Preston serves on the board of directors for Teach for America, Indianapolis, and previously served on the board of Cancer Support Community Central Indiana. Preston completed the Chief Human Resources Officer (CHRO) Program at the Wharton School at the University of Pennsylvania and holds both a master's and a bachelor's degree in health service administration from the University of Evansville. DAVE KINARD TO RETIRE AT YEAR-END Kinard's retirement follows a career focused on organizational development and talent management. Since Elanco's transition from Lilly's animal health division to an independent publicly traded company, he has played a key role in shaping Elanco's global HR infrastructure, culture and employee experience. Kinard also oversaw the company's headquarters relocation from Greenfield to Indianapolis, including the establishment of the One Health Innovation District, a life sciences innovation hub anchored by Elanco and Purdue University. "Today our employee engagement is the highest since our IPO, backed by a culture and brand in a position of strength because of Dave's dedicated leadership and enduring contributions," added Simmons. "Dave has been a trusted partner, and we appreciate his commitment to supporting Jamie through the end of the year to ensure continuity for our teams around the world, and we wish him all the best in his well-deserved retirement."

PR Newswire
Oct 22nd, 2026
Elanco names Eli Lilly's Jamie Preston chief people officer as Dave Kinard retires

Elanco Animal Health has appointed Jamie Preston as executive vice president and chief people officer, effective November 3. She succeeds Dave Kinard, who plans to retire at the end of the year and will help with the transition. Preston joins from Eli Lilly and Company, where she spent 23 years. Most recently she was vice president of HR, global compensation and workforce innovation, leading compensation for an organisation of more than 50,000 employees. "Jamie is a visionary, dynamic leader with the speed and agility that defines Elanco," said chief executive officer Jeff Simmons. Simmons said employee engagement is the highest since Elanco's IPO, crediting Kinard's leadership. Kinard also oversaw the move of the company's headquarters from Greenfield to Indianapolis.

WBIW
Oct 15th, 2026
Purdue, Elanco break ground on new One Health Research Institute in Indianapolis.

Purdue, Elanco break ground on new One Health Research Institute in Indianapolis. October 15, 2026 INDIANAPOLIS - Purdue University and Elanco Animal Health have broken ground on a new research facility designed to advance health solutions for people, animals, plants and the environment. University, industry and government leaders gathered Tuesday, Oct. 6, to mark the beginning of construction on the One Health Research Institute, part of the developing One Health Innovation District near downtown Indianapolis. The planned 150,000-square-foot facility will feature advanced research laboratories, shared equipment and research infrastructure, business incubator space, collaboration areas and facilities supporting animal health and veterinary partners. Purdue will serve as the institute's academic and research anchor, connecting faculty, students and researchers with industry partners and entrepreneurs. Elanco will contribute its animal health expertise and scientific resources while helping connect research discoveries with the development and commercialization of new solutions. The institute is intended to encourage collaboration across scientific disciplines, recognizing that human, animal, plant and environmental health are interconnected. Purdue Interim President Mitch Daniels said the project supports the university's land-grant mission while expanding its presence in Indianapolis and contributing to Indiana's economic growth. The institute is expected to create opportunities for research partnerships and innovation that could help address complex health challenges.

Feed and Additive
Oct 14th, 2026
NOVUS appoints two sales managers in Indonesia.

NOVUS appoints two sales managers in Indonesia. 14 October 2026 NOVUS has appointed veterinarians Hendri Ahadianto and Lucia Simanjuntak as sales managers in Indonesia. Based in Jakarta, they will work with customers across the country on animal health, nutrition and feed-related challenges. NOVUS has expanded its commercial team in Indonesia with the appointment of veterinarians Hendri Ahadianto and Lucia Simanjuntak as sales managers. Based in Jakarta, Ahadianto and Simanjuntak work with customers throughout Indonesia, bringing experience in animal health, nutrition, feed additives, customer relationship management and technical evaluation. According to NOVUS, their expertise strengthens the company's ability to collaborate with feed mills, integrators, nutritionists and producers as poultry, swine and dairy customers navigate changing feed costs, raw-material variability and other production challenges. Simanjuntak's expertise includes poultry nutrition and health, feed additive formulation, intestinal health risk management, and evaluating the technical and economic benefits of nutrition programs. She works with customers to connect feed mill considerations with farm performance through formulation assessment, field trials, performance data and return-on-investment analysis. "What I enjoy most is solving practical customer problems and seeing the results in the field," says Lucia Simanjuntak. "Indonesia's animal agriculture industry faces changing feed ingredients, production pressures and animal health challenges, so continuous learning and strong customer relationships are essential. I look forward to combining technical knowledge with NOVUS resources to help customers develop practical feeding programs that deliver measurable value." Ahadianto brings nearly 20 years of animal health industry experience, with a background in communication, leadership and relationship building. In his role, he combines those skills with business analysis to understand customers' challenges and identify practical options for their operations. "After many years in animal health, joining NOVUS gives me an opportunity to take on a new challenge and expand my experience in animal nutrition," Hendri Ahadianto says. "Building close relationships is important to me. I want to understand each customer's business and work alongside them to find practical solutions to the challenges they face." Rika Riantika, Senior Regional Sales Manager at NOVUS, says the different backgrounds of her two newest colleagues strengthen the support NOVUS can provide customers in Indonesia. "Lucia and Hendri bring valuable but complementary experience to our team," says Riantika. "Hendri's extensive animal health background, business perspective and ability to build strong customer relationships pair well with Lucia's experience in animal health, nutrition solutions and technical evaluation. Together, they strengthen our ability to understand what customers are facing and connect them with the expertise and resources available through NOVUS." Before joining NOVUS, Lucia Simanjuntak served as sales manager for western Indonesia with Huvepharma Animal Health Indonesia. She also served as business manager for western Indonesia with Evonik Indonesia. Simanjuntak earned her doctorate in veterinary medicine from Gadjah Mada University in Yogyakarta, Indonesia. Hendri Ahadianto previously served as a strategic account manager with Elanco Animal Health. He also held sales and technical roles with Zoetis, Pfizer Animal Health, and Romindo Primavetcom. He earned his veterinary degree from Airlangga University in Surabaya, Indonesia.